| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |